Opportunity
Generation and fluorescent formatting of aptamers targeting antiretroviral drugs (ARVs) for the detection of unreported ARV use on behalf of the CDC’s National Center for HIV, Viral Hepatitis, STD, and Tuberculosis Prevention Division of HIV Prevention.
Response due
July 31, 2026
- Agency
- CDC Office of Acquisition Services
- Estimated value
- Not stated
Key dates
- Posted
- July 29, 2026
- Response due
- July 31, 2026
Who is this buyer
Organization
Buying history
- Records110 total
- Opportunities / awards1 / 49
- Value range$0 – $290,871,939
- ActiveJuly 15, 2026 – October 26, 2026
What they buy
- Clinical (90)
- Administrative (18)
- Insurance (2)
Set-asides used
- No Set aside used (45)
- Small Business Set Aside - Total (4)
- Small Business Set Aside - Partial (1)
Who holds their work today
- WALGREEN CO.1 win · $290,871,939 · last June 14, 2022
- ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI1 win · $186,198,497 · last September 29, 2022
- NEW YORK CITY HEALTH AND HOSPITALS CORPORATION2 wins · $133,057,936 · last September 26, 2025
- THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK1 win · $85,117,198 · last September 29, 2022
- CITY OF NEW YORK FIRE DEPARTMENT1 win · $70,314,507 · last September 29, 2022
Also open from this buyer
- Safety, Prevention, Epidemiology, and Education Development for Health Care and Antimicrobial Resistance - SPEED 2027-2032Due November 8, 2026 · Clinical
View source document →
Source link on sam.gov.
Source record
- Buyer type
- Federal
- Jurisdiction
- Federal (US)
- Category
- Administrative
- Set-aside
- No Set aside used
- NAICS
- 541715
- PSC
- AJ12